image
REGENXBIO Inc. RGNX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 7.92
-18.9 %
$ 397 M
Market Cap
-1.73
P/E
BALANCE SHEET
466 M ASSETS
-18.81%
Growth Rates
1Year -18.81%
3Years -25.21%
5Years -1.32%
7Years 12.95%
10Years 63.13%
206 M LIABILITIES
-21.31%
Growth Rates
1Year -21.31%
3Years -16.12%
5Years 34.03%
7Years 44.55%
10Years 36.50%
260 M EQUITY
-16.71%
Growth Rates
1Year -16.71%
3Years -30.22%
5Years -10.42%
7Years 5.12%
10Years 47.14%
BALANCE SHEET DECOMPOSITION
Balance Sheet REGENXBIO Inc.
image
Current Assets 278 M
Cash & Short-Term Investments 235 M
Receivables 20.5 M
Other Current Assets 22.8 M
Non-Current Assets 188 M
Long-Term Investments 10.2 M
PP&E 171 M
Other Non-Current Assets 6.5 M
50.36 %4.39 %4.90 %36.76 %Total Assets$466.0m
Current Liabilities 103 M
Accounts Payable 22.8 M
Short-Term Debt 0
Other Current Liabilities 80.4 M
Non-Current Liabilities 103 M
Long-Term Debt 0
Other Non-Current Liabilities 103 M
11.05 %38.96 %49.99 %Total Liabilities$206.3m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 57.5 34.5 97.0 345.2 338.4 69.5 75.6 46.7 24.8 54.1 1.1 1.1
Short Term Investments 177.2 240.7 267.7 112.2 137.3 226.7 244.2 114.1 64.7 60.0 0 0
Receivables 20.5 26.3 28.1 32.4 43.0 38.1 8.6 0.5 1.0 2.1 1.9 1.1
Inventory 0 0 13.9 18.8 10.5 6.5 5.7 5.3 1.8 1.0 0 0
Other Current Assets 12.7 33.4 23.3 28.9 12.5 10.7 9.6 6.7 2.8 1.9 28 K 0
Total Current Assets 278.0 335.0 416.0 518.8 531.2 345.0 337.9 168.0 93.4 118.1 3.0 2.2
PP&E 171.3 192.6 206.8 192.5 120.3 39.1 28.7 14.0 9.3 0.5 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 10.2 38.9 200.6 391.9 46.8 103.8 150.8 15.6 69.4 102.5 0.3 0.3
Other Long Term Assets 6.5 7.5 9.9 10.7 9.9 10.0 26.4 1.1 0.6 0.2 0.2 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 466.0 574.0 833.3 1 113.9 708.2 497.9 543.8 198.7 172.7 221.4 3.5 2.5
LIABILITIES
Accounts Payable 22.8 22.8 27.2 11.4 10.6 6.4 4.4 4.8 1.5 1.0 0.3 0.3
Short Term Debt 0 7.1 12.0 3.5 5.0 4.8 0 0 0 0 3.8 0.7
Other Current Liabilities 80.3 100.3 89.4 100.9 62.2 22.4 16.4 9.6 8.1 3.2 5.0 3.7
Total Current Liabilities 103.2 130.3 130.4 130.5 81.4 33.7 22.2 14.4 9.7 4.3 9.2 4.7
Long Term Debt 0 82.2 88.8 84.9 70.2 8.9 5.9 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 1.1 0 0 0 0 0
Other Liabilities 103.1 49.7 97.8 134.2 175.0 1.8 3.6 1.2 1.3 0.2 0 0
Total Liabilities 206.3 262.2 317.1 349.6 330.4 47.7 35.0 15.6 11.0 4.6 9.2 4.7
EQUITY
Common Stock 5 K 4 K 4 K 4 K 4 K 4 K 4 K 3 K 3 K 3 K 0 10.9
Retained Earnings (932.1) (705.0) (441.6) (161.2) (289.1) (177.8) (83.0) (187.8) (114.6) (51.6) (28.8) (24.8)
Other Accumulative Comprehensive Income/Loss (0.7) (4.4) (15.4) (2.6) (0.4) 0.2 (0.7) (0.7) 33 K (0.7) 0 0
Total Equity 259.7 311.7 516.2 764.3 377.8 450.2 508.8 183.0 161.7 216.8 (5.7) (2.1)
Total Liabilities and Equity 466.0 574.0 833.3 1 113.9 708.2 497.9 543.8 198.7 172.7 221.4 3.5 2.5
SHARES OUTSTANDING
Common Shares Outstanding 49.5 43.7 43.2 42.4 37.3 36.7 36.6 29.9 26.4 9.2 13.1 13.1